Koch M - Search Results

1

Novel drug candidates for the treatment of metastatic colorectal cancer through global inverse gene-expression profiling.

van Noort V, Schölch S, Iskar M, Zeller G, Ostertag K, Schweitzer C, Werner K, Weitz J, Koch M, Bork P. van Noort V, et al. Among authors: koch m. Cancer Res. 2014 Oct 15;74(20):5690-9. doi: 10.1158/0008-5472.CAN-13-3540. Epub 2014 Jul 18. Cancer Res. 2014. PMID: 25038229 Free article.

2

Immune escape and survival mechanisms in circulating tumor cells of colorectal cancer.

Steinert G, Schölch S, Niemietz T, Iwata N, García SA, Behrens B, Voigt A, Kloor M, Benner A, Bork U, Rahbari NN, Büchler MW, Stoecklein NH, Weitz J, Koch M. Steinert G, et al. Among authors: koch m. Cancer Res. 2014 Mar 15;74(6):1694-704. doi: 10.1158/0008-5472.CAN-13-1885. Epub 2014 Mar 5. Cancer Res. 2014. PMID: 24599131

3

Circulating tumour cells and outcome in non-metastatic colorectal cancer: a prospective study.

Bork U, Rahbari NN, Schölch S, Reissfelder C, Kahlert C, Büchler MW, Weitz J, Koch M. Bork U, et al. Among authors: koch m. Br J Cancer. 2015 Apr 14;112(8):1306-13. doi: 10.1038/bjc.2015.88. Epub 2015 Mar 31. Br J Cancer. 2015. PMID: 25867263 Free PMC article.

4

Colorectal cancer.

Weitz J, Koch M, Debus J, Höhler T, Galle PR, Büchler MW. Weitz J, et al. Among authors: koch m. Lancet. 2005 Jan 8-14;365(9454):153-65. doi: 10.1016/S0140-6736(05)17706-X. Lancet. 2005. PMID: 15639298 Review.

5

Prognostic impact of hematogenous tumor cell dissemination in patients with stage II colorectal cancer.

Koch M, Kienle P, Kastrati D, Antolovic D, Schmidt J, Herfarth C, von Knebel Doeberitz M, Weitz J. Koch M, et al. Int J Cancer. 2006 Jun 15;118(12):3072-7. doi: 10.1002/ijc.21784. Int J Cancer. 2006. PMID: 16425256

6

Biology and significance of circulating and disseminated tumour cells in colorectal cancer.

Steinert G, Schölch S, Koch M, Weitz J. Steinert G, et al. Among authors: koch m. Langenbecks Arch Surg. 2012 Apr;397(4):535-42. doi: 10.1007/s00423-012-0917-9. Epub 2012 Feb 15. Langenbecks Arch Surg. 2012. PMID: 22350614 Review.

7

Prognostic relevance of minimal residual disease in colorectal cancer.

Bork U, Grützmann R, Rahbari NN, Schölch S, Distler M, Reissfelder C, Koch M, Weitz J. Bork U, et al. Among authors: koch m. World J Gastroenterol. 2014 Aug 14;20(30):10296-304. doi: 10.3748/wjg.v20.i30.10296. World J Gastroenterol. 2014. PMID: 25132746 Free PMC article. Review.

8

Overexpression of SIX1 is an independent prognostic marker in stage I-III colorectal cancer.

Kahlert C, Lerbs T, Pecqueux M, Herpel E, Hoffmeister M, Jansen L, Brenner H, Chang-Claude J, Bläker H, Kloor M, Roth W, Pilarsky C, Rahbari NN, Schölch S, Bork U, Reissfelder C, Weitz J, Aust D, Koch M. Kahlert C, et al. Among authors: koch m. Int J Cancer. 2015 Nov 1;137(9):2104-13. doi: 10.1002/ijc.29596. Epub 2015 May 21. Int J Cancer. 2015. PMID: 25951369

9

Metastatic Spread Emerging From Liver Metastases of Colorectal Cancer: Does the Seed Leave the Soil Again?

Rahbari NN, Bork U, Schölch S, Reissfelder C, Thorlund K, Betzler A, Kahlert C, Schneider M, Ulrich AB, Büchler MW, Weitz J, Koch M. Rahbari NN, et al. Among authors: koch m. Ann Surg. 2016 Feb;263(2):345-52. doi: 10.1097/SLA.0000000000001341. Ann Surg. 2016. PMID: 26501709

10

Detection of disseminated tumour cells as a potential surrogate-marker for monitoring palliative chemotherapy in colorectal cancer patients.

Staritz P, Kienle P, Koch M, Benner A, von Knebel Doeberitz M, Rudi J, Weitz J. Staritz P, et al. Among authors: koch m. J Exp Clin Cancer Res. 2004 Dec;23(4):633-9. J Exp Clin Cancer Res. 2004. PMID: 15743034 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,947 results

Search Page

Filters